We are pleased to announce that Dr. Ippei Shimizu from National Cerebral and Cardiovascular Center Research Institute, Japan will join Second Conjoint RIKEN – ISM 2026 as a speaker and give a presentation entitled “TMAO as a Senometabolite: Microbial Regulation of Cardiovascular Aging and Host Resilience“.